Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)
NCT00818727 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2009-01-08
Summary
SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.
Conditions
- Bone Density
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 1 Day
- Max Age
- 7 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2011-01-31
More Related Trials
-
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram
NCT00697268 ·Status: COMPLETED
-
Antidepressant Treatment of Melancholia in Late Life
NCT00000378 ·Status: COMPLETED ·Phase: PHASE4
-
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
NCT01312922 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression
NCT03126188 ·Status: COMPLETED
-
Serotonin Function During Depression
NCT00033787 ·Status: COMPLETED
-
Influence of Oxycodone on Individuals Taking an SSRI
NCT05730062 ·Status: UNKNOWN ·Phase: PHASE1
-
Examination of Brain Serotonin Receptors in Patients With Mood Disorders
NCT00026832 ·Status: COMPLETED
-
Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
NCT00902421 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD
NCT02473783 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline
NCT01028482 ·Status: COMPLETED ·Phase: NA
-
Thyroid Medication and Antidepressants for Treating Major Depression
NCT00208702 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation
NCT05893173 ·Status: COMPLETED
-
Human Cerebral Blood Flow and Serotonin
NCT05957094 ·Status: UNKNOWN ·Phase: NA
-
Pharmacogenetics of Antidepressant-Induced Disinhibition
NCT03953014 ·Status: RECRUITING
-
Benefits of Switching Antidepressants Following Early Nonresponse
NCT00519012 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
NCT00781326 ·Status: TERMINATED ·Phase: PHASE4
-
Analysis of Peripheral Serotonin Levels in a Control Cohort
NCT06910774 ·Status: COMPLETED
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
NCT04533529 ·Status: COMPLETED ·Phase: PHASE3
-
Depression and Traumatic Brain Injury
NCT00254007 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
NCT04532749 ·Status: TERMINATED ·Phase: PHASE3
-
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250627 ·Status: COMPLETED ·Phase: PHASE3
-
IMI PROTECT(WP2): Antidepressants & Fractures
NCT01587729 ·Status: COMPLETED